Press "Enter" to skip to content

New patent for Osmotica Pharm drug OSMOLEX ER

1
Copyright © DrugPatentWatch. Originally published at New patent for Osmotica Pharm drug OSMOLEX ER

Annual Drug Patent Expirations for OSMOLEX+ER
Annual Drug Patent Expirations for OSMOLEX+ER

Osmolex Er is a drug marketed by Osmotica Pharm and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

Drug patent litigation for OSMOLEX ER.

This drug has eleven patent family members in nine countries.

The generic ingredient in OSMOLEX ER is amantadine hydrochloride. One supplier is listed for this compound. Additional details are available on the amantadine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Osmotica Pharm drug OSMOLEX ER

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions